The dollar dropped to a one-month low after President Donald Trump appeared to soften his approach toward tariffs on China.

US stocks closed lower afer the S&P 500 touched an intraday record high early in the day. As tariff worries eased, mixed ...

LONDON (Reuters) - It's a big week ahead as the U.S. Federal Reserve, European Central Bank and Bank of Canada hold their first meetings of 2025. Into the mix go earnings from heavyweights including ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

The three laggards were energy stocks, off 1.1%, industrials, sliding 0.5%, and consumer staples, falling 0.4%. The S&P 500 reached new records on Friday as optimism around the start of President ...

Novo Nordisk’s NVO amycretin, which targets GLP-1 and amylin in one molecule, generated 24% placebo-adjusted weight loss in a ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much ...

The dollar dropped to a one-month low after President Donald Trump appeared to soften his approach toward tariffs on China.

Novo Nordisk reported strong early-stage results for its once-a-week obesity drug. Early Friday, Novo Nordisk stock jumped. Eli Lilly fell.

The big hope is that Europe will move faster to implement reforms in the face of competitive threats from the U.S.